Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 2
1956 1
1957 1
1964 1
1966 1
1968 2
1969 1
1970 2
1971 3
1972 3
1973 4
1974 5
1975 4
1976 5
1977 16
1978 10
1979 11
1980 20
1981 22
1982 17
1983 19
1984 20
1985 34
1986 24
1987 28
1988 25
1989 31
1990 25
1991 21
1992 23
1993 12
1994 20
1995 29
1996 17
1997 27
1998 24
1999 22
2000 49
2001 48
2002 57
2003 49
2004 54
2005 65
2006 56
2007 58
2008 54
2009 61
2010 108
2011 148
2012 160
2013 168
2014 166
2015 191
2016 187
2017 216
2018 222
2019 203
2020 253
2021 343
2022 325
2023 324
2024 353
2025 347
2026 56

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,404 results

Results by year

Filters applied: . Clear all
Page 1
Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency.
Biederstädt A, Basar R, Park JM, Uprety N, Shrestha R, Reyes Silva F, Dede M, Watts J, Acharya S, Xiong D, Liu B, Daher M, Rafei H, Banerjee P, Li P, Islam S, Fan H, Shanley M, Jin J, Kumar B, Woods V, Lin P, Tiberti S, Nunez Cortes AK, Jiang XR, Biederstädt I, Zhang P, Li Y, Rawal S, Liu E, Muniz-Feliciano L, Deyter GM, Shpall EJ, Fowlkes NW, Chen K, Rezvani K. Biederstädt A, et al. Among authors: kumar b. Cancer Cell. 2025 Nov 10;43(11):2069-2088.e11. doi: 10.1016/j.ccell.2025.07.021. Epub 2025 Aug 21. Cancer Cell. 2025. PMID: 40845844 Free PMC article.
CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis.
Acharya S, Basar R, Daher M, Rafei H, Li P, Uprety N, Ensley E, Shanley M, Kumar B, Banerjee PP, Melo Garcia L, Lin P, Mohanty V, Kim KH, Jiang X, Pan Y, Li Y, Liu B, Nunez Cortes AK, Zhang C, Fathi M, Rezvan A, Montalvo MJ, Cha SL, Reyes-Silva F, Shrestha R, Guo X, Kundu K, Biederstädt A, Muniz-Feliciano L, Deyter GM, Kaplan M, Jiang XR, Liu E, Jain A, Roszik J, Fowlkes NW, Solis Soto LM, Raso MG, Khoury JD, Lin P, Vega F, Varadarajan N, Chen K, Marin D, Shpall EJ, Rezvani K. Acharya S, et al. Among authors: kumar b. Cancer Discov. 2024 Oct 4;14(10):1879-1900. doi: 10.1158/2159-8290.CD-24-0096. Cancer Discov. 2024. PMID: 38900051 Free PMC article.
Distinct components of mRNA vaccines cooperate to instruct efficient germinal center responses.
Castaño D, Bettini E, Kumar B, Chudnovskiy A, Siv A, Protti G, Nakadakari-Higa S, Ceglia S, De Luna N, Chiu JE, Lederer K, Li SH, Ibrahim H, Muramatsu H, Mdluli T, Abraham E, Sahingur SE, Maillard I, Tam YK, Shin S, Hensley SE, Miner JJ, Lipinszki Z, Reboldi A, Pardi N, Spreafico R, Victora GD, Locci M. Castaño D, et al. Among authors: kumar b. Cell. 2025 Dec 24;188(26):7461-7480.e23. doi: 10.1016/j.cell.2025.11.023. Epub 2025 Dec 16. Cell. 2025. PMID: 41406961 Free PMC article.
The UCL-Lancet Commission on Migration and Health: the health of a world on the move.
Abubakar I, Aldridge RW, Devakumar D, Orcutt M, Burns R, Barreto ML, Dhavan P, Fouad FM, Groce N, Guo Y, Hargreaves S, Knipper M, Miranda JJ, Madise N, Kumar B, Mosca D, McGovern T, Rubenstein L, Sammonds P, Sawyer SM, Sheikh K, Tollman S, Spiegel P, Zimmerman C; UCL–Lancet Commission on Migration and Health. Abubakar I, et al. Among authors: kumar b. Lancet. 2018 Dec 15;392(10164):2606-2654. doi: 10.1016/S0140-6736(18)32114-7. Epub 2018 Dec 5. Lancet. 2018. PMID: 30528486 Free PMC article. Review.
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML.
Kumar B, Singh A, Basar R, Uprety N, Li Y, Fan H, Cortes AKN, Kaplan M, Acharya S, Shaim H, Xu AC, Wu M, Ensley E, Fang D, Banerjee PP, Garcia LM, Tiberti S, Lin P, Rafei H, Munir MN, Moore M, Shanley M, Mendt M, Kerbauy LN, Liu B, Biederstädt A, Gokdemir E, Ghosh S, Kundu K, Reyes-Silva F, Jiang XR, Wan X, Gilbert AL, Dede M, Mohanty V, Dou J, Zhang P, Liu E, Muniz-Feliciano L, Deyter GM, Jain AK, Rodriguez-Sevilla JJ, Colla S, Garcia-Manero G, Shpall EJ, Chen K, Abbas HA, Rai K, Rezvani K, Daher M. Kumar B, et al. Sci Transl Med. 2024 Sep 11;16(764):eadp0004. doi: 10.1126/scitranslmed.adp0004. Epub 2024 Sep 11. Sci Transl Med. 2024. PMID: 39259809 Free PMC article.
CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells.
Rafei H, Basar R, Acharya S, Hsu YS, Liu P, Zhang D, Bohn T, Liang Q, Mohanty V, Upadhyay R, Li P, Phadatare P, Dede M, Xiong D, Fan H, Jones CM, Kunz S, Daher M, Nunez Cortes AK, Shanley M, Liu B, Moseley SM, Zhang C, Fang D, Banerjee P, Uprety N, Li Y, Shrestha R, Wan X, Shen H, Woods V, Gilbert AL, Rawal S, Dou J, Tan Y, Park JM, Reyes Silva F, Biederstädt A, Kaplan M, Jiang XR, Biederstädt I, Kumar B, Tiberti S, Moore M, Jin J, Yang RZ, Muniz-Feliciano L, Rosemore S, Lin P, Deyter GM, Fowlkes NW, Jain AK, Marin D, Maitra A, Chen K, Bopp T, Shpall EJ, Rezvani K. Rafei H, et al. Among authors: kumar b. Nature. 2025 Jul;643(8073):1076-1086. doi: 10.1038/s41586-025-09087-8. Epub 2025 Jun 4. Nature. 2025. PMID: 40468083 Free PMC article.
Overcoming CD226-related immune evasion in acute myeloid leukemia with CD38 CAR-engineered NK cells.
Melo Garcia L, Gangadharan A, Banerjee P, Li Y, Zeng AGX, Rafei H, Lin P, Kumar B, Acharya S, Daher M, Muniz-Feliciano L, Deyter GM, Dominguez G, Park JM, Reyes Silva F, Nunez Cortes AK, Basar R, Uprety N, Shanley M, Kaplan M, Liu E, Shpall EJ, Rezvani K. Melo Garcia L, et al. Among authors: kumar b. Cell Rep. 2025 Jan 28;44(1):115122. doi: 10.1016/j.celrep.2024.115122. Epub 2025 Jan 3. Cell Rep. 2025. PMID: 39754720 Free PMC article.
ICON 2023: International Scientific Tendinopathy Symposium Consensus - the core outcome set for Achilles tendinopathy (COS-AT) using a systematic review and a Delphi study of professional participants and patients.
de Vos RJ, Gravare Silbernagel K, Malliaras P, Visser TS, Alfredson H, Akker-Scheek IVD, van Ark M, Brorsson A, Chimenti R, Docking S, Eliasson P, Farnqvist K, Haleem Z, Hanlon SL, Kaux JF, Kearney RS, Kirwan PD, Kulig K, Kumar B, Lewis T, Longo UG, Lui TH, Maffulli N, Mallows AJ, Masci L, McGonagle D, Morrissey D, Murphy MC, Newsham-West R, Nilsson-Helander KM, Norris R, Oliva F, O'Neill S, Peers K, Rio EK, Sancho I, Scott A, Seymore KD, Soh SE, Vallance P, Verhaar JAN, van der Vlist AC, Weir A, Zellers JA, Vicenzino B. de Vos RJ, et al. Among authors: kumar b. Br J Sports Med. 2024 Oct 22;58(20):1175-1186. doi: 10.1136/bjsports-2024-108263. Br J Sports Med. 2024. PMID: 39271248 Free article.
4,404 results